Rigel Reports First Quarter 2020 Financial Results and Provides Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Rigel Pharma (RIGL) Reports In-Line Q1 EPS, Revenues Miss
May 5, 2020 4:38 PM EDTRigel Pharma (NASDAQ: RIGL) reported Q1 EPS of $0.13, in-line with the analyst estimate of $0.13. Revenue for the quarter came in at $55.76 million versus the consensus estimate of $56.71 million.
"During these extraordinary times, we continue to execute on our business strategy while maintaining... More
